Background Epicardial adipose tissue (EAT) measured by echocardiography has been proposed to be associated with metabolic syndrome and increased cardiovascular risks. However, its independent association with fatty liver disease and…
There is much within the targeted neonatal echocardiography (TNE) consensus statement we endorse, particularly the clinical indications, the need for training structures, and the importance of collaboration with other specialties…
Background The appropriateness use criteria (AUC) for the performance of transthoracic echocardiography were recently revised. The aims of this study were to evaluate the 2011 AUC for echocardiography for their…
Experience matters in medicine. In the current era of lengthy training programs and sub-subspecialization, this statement is hard to dispute. The concept that experience matters is not limited to medicine,…
Background Despite several efforts using two-dimensional echocardiography and cardiac magnetic resonance in the diagnosis of left ventricular noncompaction (LVNC), there are no universally accepted diagnostic criteria. The aim of this…
Background Left ventricular noncompaction (LVNC) cardiomyopathy is variably defined by numerous trabeculations, deep intertrabecular recesses, and noncompacted-to-compacted (NC/C) ratio >2. Limited studies exist on the reproducibility of diagnosing LVNC. Methods…
Background Transcatheter aortic valve implantation (TAVI) is an alternative to conventional surgery in high-risk patients with severe aortic stenosis (AS), but data regarding mitral regurgitation (MR) characteristics and changes after…
Background The impact of mitral valve surgery on left ventricular outflow tract (LVOT) dimensions is unclear. Real-time three-dimensional transesophageal echocardiography permits excellent visualization of the LVOT and might improve standard…
Background It has been suggested that myocardial systolic impairment may not be accurately detected by the evaluation of endocardial excursion alone. The aim of this study was to test the…
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disease with both variable penetrance and a wide spectrum of phenotypic expression. Although there are several established risk factors for sudden cardiac death…
